Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03464851 · ClinicalTrials.gov registry record
Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 51
- Enrollment target
NCT03464851: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT03464851 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03464851 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the accuracy of a new non-invasive device, the Carotid Stenotic Scan (CSS), to check for stenosis of the internal carotid artery (ICA) as compared to a carotid ultrasound study.
Primary Outcome
Primary analysis % agreement CSS and carotid duplex ultrasound (SRUCC interpretation) for ICA stenosis
Interventions
- DIAGNOSTIC_TEST Carotid Stenotic Scan (CSS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2020-02-01 |
Why NCT03464851 stopped before completion
NCT03464851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Carotid Stenotic Scan (CSS) is the first listed.
NCT03464851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03464851 about?
NCT03464851 is a clinical study titled "Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis". The purpose of this study is to determine the accuracy of a new non-invasive device, the Carotid Stenotic Scan (CSS), to check for stenosis of the internal carotid artery (ICA) as compared to a carotid ultrasound study.
What is the current status of trial NCT03464851?
This trial is currently terminated. The enrollment target is 51 participants. The study started on 2018-03-08. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT03464851?
The interventions under investigation include: Carotid Stenotic Scan (CSS) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03464851?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI